Showing results (211-220 of 313) with videos related to

Sort By:
Pageof 32
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 16, 2002
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaireDavid Cella, Chanita Hughes, Amy Peterman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trialsCaryn Lerman, Christopher Jepson, E Paul Wileyto, et al.
Molecular Genetics & Genomic Medicine|September 2, 2022
Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genesJacob G Comeaux, Julie O Culver, John E Lee, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|October 23, 2003
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trialCaryn Lerman, Peter G Shields, E Paul Wileyto, et al.
American Journal of Medical Genetics|January 25, 2002
All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test resultsChanita Hughes, Caryn Lerman, Marc Schwartz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 6, 2012
The DRD4 exon III VNTR, bupropion, and associations with prospective abstinenceAndrew W Bergen, Harold S Javitz, Li Su, et al.
Drug and Alcohol Dependence|October 8, 2013
Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept studyRebecca L Ashare, E Paul Wileyto, Kosha Ruparel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 17, 2010
Mouse model predicts effects of smoking and varenicline on event-related potentials in humansNoam D Rudnick, Andrew A Strasser, Jennifer M Phillips, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokersRiju Ray, Kosha Ruparel, Andrew Newberg, et al.
Pageof 32